
BPC-157 / TB-500 Blend

For in vitro research only
A higher-strength 20 mg blend of BPC-157 and TB-500 supplied as a lyophilized vial for extended tissue-repair research.
Size
Promotion
Everything you need to start is included.
New
Technical specification
Key attributes
Each vial is intended for laboratory use only.
Research usage
This 20 mg blend pairs BPC-157, a stable gastric pentadecapeptide that promotes angiogenesis and growth-factor regulation, with TB-500, a Thymosin Beta-4 fragment that supports cell migration and tissue regeneration. The higher strength supports extended research into their complementary roles in recovery.
Research attributes the combination’s potential to distinct yet overlapping pathways — improved blood flow and reduced inflammation from BPC-157, and enhanced cellular migration from TB-500. Early animal studies suggest faster recovery and improved structural integrity of repaired tissues, with most evidence still preclinical.
Both peptides have shown favorable tolerability in animal research. Human clinical safety data are limited and the combined profile remains largely preclinical and not fully characterized.

BPC-157 / TB-500 Blend
Research journal
BPC-157 and TB-500 are frequently studied together; a blend supplies both peptides in a single lyophilised vial for repair-related research.
A synthetic pentadecapeptide derived from a protective protein in human gastric juice, studied for tissue repair, gut protection, and systemic healing.
A synthetic fragment of Thymosin beta-4, studied for actin regulation, tissue regeneration, and complementary use with BPC-157 in repair protocols.